Formulations for hydrophobic pharmaceutical agents
申请人:——
公开号:US20010012844A1
公开(公告)日:2001-08-09
The present invention features formulations, including liquid, semi-solid or solid pharmaceutical formulations, that improve the oral bioavailability of hydrophobic pharmaceutical agents, such as quinazoline-, nitrothiazole-, and indolinone-based compounds. Also featured are formulations for parenteral delivery of such hydrophobic pharmaceutical agents, as well as methods of making and using both types of formulations.
FORMULATIONS FOR HYDROPHOBIC PHARMACEUTICAL AGENTS
申请人:Sugen, Inc.
公开号:EP1014953A2
公开(公告)日:2000-07-05
ANTIBIOTIC COMPOUNDS AND COMPOSITIONS, AND METHODS FOR IDENTIFICATION THEREOF
申请人:Fred Hutchinson Cancer Research Center
公开号:US20150126519A1
公开(公告)日:2015-05-07
Disclosed herein are compounds and methods for inhibiting bacterial DNA repair enzymes, including AddAB and RecBCD helicase-nucleases. Pharmaceutical compositions and methods for treating a subject with an antibacterial agent are also disclosed herein.